SCHEMBL27081925

SCHEMBL27081925

CC(C)(C)OC(=O)N(CCN1Cc2cc(Br)ccc2C1=O)C[C@@H]1CCC(=O)N1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 2/20 0.32
▸ WDR77 Q9BQA1 2/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32
▸ GABRA3 P34903 1/20 0.32
▸ GABRA2 P47869 1/20 0.32
▸ GABRB2 P47870 1/20 0.32
▸ GABRA6 Q16445 1/20 0.32
▸ CSNK1A1 P48729 2/20 0.32
▸ SALL4 Q9UJQ4 2/20 0.32
▸ GSPT1 P15170 1/20 0.32
▸ IKZF3 Q9UKT9 1/20 0.32
▸ DDB1 Q16531 3/20 0.31
▸ CRBN Q96SW2 3/20 0.31
▸ METAP1 P53582 1/20 0.31
▸ CCNB2 O95067 1/20 0.31
▸ CDK1 P06493 1/20 0.31
▸ CCNB1 P14635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29984097 1.00 PRMT5 (0.32) PRMT5WDR77GABRA1GABRG2GABRB3
SCHEMBL27080877 0.87 PRMT5 (0.35) PRMT5WDR77CSNK1A1SALL4GSPT1
SCHEMBL27080703 0.87 PRMT5 (0.35) PRMT5WDR77CSNK1A1SALL4GSPT1
SCHEMBL29983196 0.84 PRMT5 (0.35) PRMT5WDR77
SCHEMBL25688688 0.83 PDCD1 (0.37) CD274PDCD1
SCHEMBL29983714 0.76 CD274 (0.42) CD274PDCD1
SCHEMBL29984044 0.73 CD274 (0.37) CD274PDCD1
SCHEMBL24687471 0.73 DDB1 (0.33) DDB1CRBN
SCHEMBL27080770 0.73 PRF1 (0.34) PRMT5WDR77CSNK1A1SALL4GSPT1
SCHEMBL30432457 0.72 SRD5A1 (0.33) DDB1CRBNMETAP1CD274PDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313968-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2024-02-07 — — EP disclosed
Send feedback